巨子生物(02367)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02367 巨子生物

未开盘 11-19 16:08:17

49.650

-0.200

-0.40%

最高50.800	最低48.550	成交量160.02万
今开50.800	昨收49.850	日振幅4.51%
总市值510.51亿	流通市值510.51亿	总股本10.28亿
成交额7,879万	换手率0.16%	流通股本10.28亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02367","market":"HK","secType":"STK","nameCN":"巨子生物","latestPrice":49.65,"timestamp":1732003697015,"preClose":49.85,"halted":0,"volume":1600200,"delay":0,"floatShares":1028220000,"shares":1028220000,"eps":1.5995077,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.2,"latestTime":"11-19 16:08:17","open":50.8,"high":50.8,"low":48.55,"amount":78785407,"amplitude":0.045135,"askPrice":49.65,"askSize":12200,"bidPrice":49.6,"bidSize":2600,"shortable":3,"etf":0,"ttmEps":1.9337533016750212,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732066200000},"adr":0,"listingDate":1667491200000,"adjPreClose":49.85,"dividendRate":0.009529,"openAndCloseTimeList":[[1731979800000,1731988800000],[1731992400000,1732003200000]],"volumeRatio":0.41323970216472,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02367","defaultTab":"news","newsList":[{"id":"2484610069","title":"巨子生物11月18日获主力加仓1073万元 环比增加470.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484610069","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484610069?lang=zh_cn&edition=full","pubTime":"2024-11-18 16:16","pubTimestamp":1731917814,"startTime":"0","endTime":"0","summary":"11月18日, 巨子生物股价涨0.71%，报收49.85元，成交金额1.24亿元，换手率0.24%，振幅7.07%，量比0.62。巨子生物今日主力资金净流入1073万元，上一交易日主力净流入188万元，今日环比增加470.74%。该股近5个交易日下跌8.17%，主力资金累计净流入3381万元；近20日主力资金累计净流入8367万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118161744abcbdb7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118161744abcbdb7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1207","02367"],"gpt_icon":0},{"id":"2484915667","title":"【券商聚焦】高盛升巨子生物(02367)目标价11.78%至56港元 对美妆行业整体看法保持积极","url":"https://stock-news.laohu8.com/highlight/detail?id=2484915667","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484915667?lang=zh_cn&edition=full","pubTime":"2024-11-18 10:23","pubTimestamp":1731896610,"startTime":"0","endTime":"0","summary":"金吾财讯 | 高盛发布研报指出，巨子生物控股 在2024年双十一期间实现了强劲的GMV增长，其中Mia Gu和Collgene品牌的GMV分别实现了80%+和150%+的同比增长。高盛对美妆行业的整体看法保持积极。高盛根据最新的业绩情况和市场环境，将巨子生物控股2024至2026财年的收入预测分别上调至22.5%、26.9%和31.3%。同时，考虑到公司在行业中的领导地位和良好的增长前景，该行将目标价从50.10港元上调至56港元，并维持“买入”评级。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/YzgwMTczMTA1NDUyODEwNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YzgwMTczMTA1NDUyODEwNQ==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1947888","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367"],"gpt_icon":0},{"id":"2483343360","title":"胶原蛋白成“印钞机”！各路玩家跑步进场，有企业加速“出海”抢市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2483343360","media":"时代周报-时代在线","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483343360?lang=zh_cn&edition=full","pubTime":"2024-11-15 16:09","pubTimestamp":1731658140,"startTime":"0","endTime":"0","summary":"从时间线来看，国内胶原蛋白企业IPO之风起于2022年左右。此次上市的创健医疗，在胶原蛋白行业也并非新玩家。早于2022年，时代财经便已获悉创健医疗有上市计划。锦波生物的营收重心是医美注射用的重组胶原蛋白。医美注射成为各家企业鏖战的下一个新战场。目前，国内获批的胶原蛋白注射剂寥寥无几，有不少企业正在暗中发力，除了创健医疗之外，巨子生物、江山聚源亦在布局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-11-15/doc-incwcvce9461904.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-11-15/doc-incwcvce9461904.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688363","BK1207","BK0229","301371","02367","BK0239"],"gpt_icon":0},{"id":"2483563843","title":"第十一届“新股最具增长动力奖”：新星璀璨升腾，增长势如虹","url":"https://stock-news.laohu8.com/highlight/detail?id=2483563843","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483563843?lang=zh_cn&edition=full","pubTime":"2024-11-14 14:26","pubTimestamp":1731565583,"startTime":"0","endTime":"0","summary":"在全球百年未有之大变局中，在全球局势深刻变革之际，香港充分发挥其“超级联络人”与“超级增值人”的优势，并依托背靠祖国、联通全球的独特优势，正积极吸引全球资本的广泛关注。与此同时，港股100强研究中心，作为金融创新与发展的积极推动者，已成为投资者洞察港股市场动态、上市公司展示品牌价值的核心平台。","market":"us","thumbnail":"https://images.finet.hk/photoLib/title/202411_1/cbb45cd4-7512-4ca3-9230-3c3eca153176.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202411_1/cbb45cd4-7512-4ca3-9230-3c3eca153176.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/6735980fbde0b3178fdd0cc9","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["LU2476274308.USD","09878","LU2778985437.USD","HSTECH","BK1213","01698","03660","02145","02076","BK1188","06655","BK1249","YANG","IE0032431581.USD","09896","BK1124","BK1207","BK1246","02423","BK1095","09638","HSCEI","BK1097","BK1135","BK1128","02367"],"gpt_icon":1},{"id":"2483150348","title":"【券商聚焦】招银国际升巨子生物(02367)目标价6.6% 指双十一期间两大核心品牌线上增速靓丽","url":"https://stock-news.laohu8.com/highlight/detail?id=2483150348","media":"金吾财讯","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483150348?lang=zh_cn&edition=full","pubTime":"2024-11-14 13:35","pubTimestamp":1731562520,"startTime":"0","endTime":"0","summary":"可复美与可丽金的线上全渠道GMV分别同比增长超80%和超150%，较今年“618”均有提速。可复美和可丽金在抖音平台爆发式增长，双十一期间分别同比增长超100%和超500%。可复美胶原棒延续高增长，新品表现亮眼。可丽金新品发力，增长潜力快速释放。该行认为，不断丰富的产品矩阵将推动品牌长期增长。维持“买入”评级。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/YjEwODMyZjRkNWI4NjVjNzFhNGY4NWE0ZDExNzMxMDU0NzE5MDIz.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YjEwODMyZjRkNWI4NjVjNzFhNGY4NWE0ZDExNzMxMDU0NzE5MDIz.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1947717","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367"],"gpt_icon":0},{"id":"2483893850","title":"招银国际：维持巨子生物(02367)“买入”评级 目标价66.15港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483893850","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483893850?lang=zh_cn&edition=full","pubTime":"2024-11-14 09:51","pubTimestamp":1731549105,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，招银国际发布研究报告称，维持巨子生物“买入”评级，继续看好公司护肤品类的快速增长，预期注射类胶原蛋白产品将于1Q25E获批。小幅上调公司FY24-26的盈利预测，基于DCF模型，上调目标价至66.15港元。招银国际主要观点如下：2024年双十一收官，公司两大核心品牌可复美与可丽金线上增速靓丽。双十一期间，可复美与可丽金的线上全渠道GMV分别同比增长超80%和超150%，较今年“618”均有提速。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1210725.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02367"],"gpt_icon":0},{"id":"2483024676","title":"巨子生物11月13日主力资金流入1751万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2483024676","media":"市场透视","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483024676?lang=zh_cn&edition=full","pubTime":"2024-11-13 16:15","pubTimestamp":1731485703,"startTime":"0","endTime":"0","summary":"11月13日, 巨子生物股价跌0.68%，报收51.20元，成交金额1.75亿元，换手率0.33%，振幅3.78%，量比0.77。巨子生物今日主力资金净流入1751万元，连续3日净流入，上一交易日主力净流入598万元，今日环比增加192.81%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为50.00%，平均涨幅为1.75%。该股近5个交易日下跌7.61%，主力资金累计净流入2238万元；近20日主力资金累计净流入1.05亿元，其中净流入天数为13日。该股主力净额占比0.03%，港股市场排名129/2644。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113161511abbcaf33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113161511abbcaf33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1207","02367"],"gpt_icon":0},{"id":"2483187025","title":"【券商聚焦】浦银国际指整体电商销售回暖 美妆板块“双11”表现良好","url":"https://stock-news.laohu8.com/highlight/detail?id=2483187025","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483187025?lang=zh_cn&edition=full","pubTime":"2024-11-13 15:20","pubTimestamp":1731482405,"startTime":"0","endTime":"0","summary":"金吾财讯 | 浦银国际表示，史上最长的“双11”收官，个护美妆销售增长喜人。尽管同比增长中包含了一定的大促时间延长带来的规模增长，但该行仍认为，本次“双11”线上美妆赛道的增长回归较为快速的增长轨道。该行指，相较往年国产品牌在“双11”期间的强势，今年国际品牌热度明显回升。随着整体电商销售回暖，本次美妆板块“双11”表现良好。","market":"sh","thumbnail":"https://static.szfiu.com/news/20241108/YzgwMTczMTA1NDUyODEwNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YzgwMTczMTA1NDUyODEwNQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1947651","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02367","BK1207"],"gpt_icon":0},{"id":"2483049850","title":"浦银国际：“双11”美妆销售增长良好 国产品牌高基数下表现稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=2483049850","media":"智通财经","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483049850?lang=zh_cn&edition=full","pubTime":"2024-11-13 13:40","pubTimestamp":1731476412,"startTime":"0","endTime":"0","summary":"随着整体电商销售回暖，本次美妆板块“双11”表现良好。国际大牌反扑，国产品牌替代仍是主流相较往年国产品牌在“双11”期间的强势，今年国际品牌热度明显回升。在同一榜单中，国产品牌珀莱雅去年“双11”亦排名第一，位置稳固。根据浦银国际估算，主品牌全平台“双11”GMV同比增长20%左右。整体看来，巨子生物旗下品牌在“双11”期间表现符合预期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1210266.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1610","LU0588546209.SGD","LU0456842615.SGD","LU0130103400.USD","BK4524","IE00B29SXG58.USD","LU1008478684.HKD","LU0181495838.USD","LU0348825331.USD","IE00BZ08YS42.EUR","LU1044874839.SGD","LU0049853897.USD","BK4551","LU0214875030.USD","BK1521","IE0034224299.USD","89618","LU0228659784.USD","LU0593848301.USD","LU1823568750.SGD","HBBD.SI","LU1688375341.USD","09618","LU0370786039.SGD","JD","BK4505","LU0594300419.USD","LU0320764599.SGD","603605","IE00B3M56506.USD","BK1249","BABA","02367","BK4558","LU0054450605.USD","LU1282648689.USD","LU0868486357.SGD","BK4122","89988","LU0865486749.SGD","IE00BFMHRM44.USD","LU0127658192.USD","LU0791590937.USD","LU1152091168.USD","BK1588","09988","BK4502","LU1997245177.USD","LU0067412154.USD","BK4579"],"gpt_icon":1},{"id":"2483202018","title":"《大行》招商证券：尽管周期拉长“双十一”仍超预期  行业首选阿里(BABA.US)和巨子生物(02367.HK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2483202018","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483202018?lang=zh_cn&edition=full","pubTime":"2024-11-13 09:57","pubTimestamp":1731463020,"startTime":"0","endTime":"0","summary":"招商证券发表研报指，据行业数据显示，今年“双十一”全网销售额按年增长26.6%，达1.44万亿元人民币(下同)。招商证券表示，相对今年“618”及去年“双十一”，今年“双十一”增速有所回升，不过部分受惠于周期拉长7至10日。另外，直播电商销售额占全网销售额比例，由去年“双十一”的19%提升至今年的23%，但相较今年“618”的27%则有所下降。另外，招商证券认为化妆品及运动品类销售额增长基本符合预期，并且较“618”期间有所加速。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20211101160823562_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20211101160823562_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1396203/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK0012","02367","600999","BK0188","BK0010","BK0183","BK1207","BK1564","BK0028","BK1147","BK0276"],"gpt_icon":1},{"id":"2483092474","title":"南向资金11月12日净卖出巨子生物98.28万股 连续5日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2483092474","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483092474?lang=zh_cn&edition=full","pubTime":"2024-11-13 09:30","pubTimestamp":1731461416,"startTime":"0","endTime":"0","summary":"11月12日，南向资金减持巨子生物98.28万股连续5日减持。截止当日收盘，港股通共持有巨子生物17396.62万股，占流通股16.91%。巨子生物近5个交易日下跌6.87%，港股通累计减持349.99万股；近20个交易日下跌0.29%，港股通累计减持150.71万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113093225a231f17c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113093225a231f17c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1207","02367"],"gpt_icon":0},{"id":"2482743151","title":"巨子生物盘中异动 股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482743151","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482743151?lang=zh_cn&edition=full","pubTime":"2024-11-12 13:13","pubTimestamp":1731388405,"startTime":"0","endTime":"0","summary":"2024年11月12日下午盘13时13分，巨子生物股票出现异动，股价大幅跳水5.05%。截至发稿，该股报51.750港元/股，成交量273.16万股，换手率0.27%，振幅6.24%。机构评级方面，在所有25家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。巨子生物股票所在的生物技术行业中，整体跌幅为0.18%。其相关个股中，宜明昂科-B、东曜药业-B、奥星生命科技涨幅较大，振幅较大的相关个股有绿竹生物-B、药明合联、宜明昂科-B，振幅分别为18.42%、17.14%、16.04%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111213132598e41fa3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111213132598e41fa3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02367","BK1207"],"gpt_icon":0},{"id":"2482422387","title":"聚焦双十一：被卖爆的可复美撑起巨子生物，超高毛利率能否长久？","url":"https://stock-news.laohu8.com/highlight/detail?id=2482422387","media":"全球财说-官方","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482422387?lang=zh_cn&edition=full","pubTime":"2024-11-12 12:28","pubTimestamp":1731385719,"startTime":"0","endTime":"0","summary":"作者：潘妍      出品：全球财说      在2024年热门成分原料中，重组胶原蛋白必占一席之位。      弗若斯特沙利文数据显示，2025年胶原蛋白市场份额将超越玻尿酸成为护肤品第一大原料成....","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/OioO4DqvHyXS1F636vCcbcVicAmkeDYgfYbWYWdag5_lMAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OioO4DqvHyXS1F636vCcbcVicAmkeDYgfYbWYWdag5_lMAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241112A047FM00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241112A047FM00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["BK1207","02367"],"gpt_icon":0},{"id":"1187044096","title":"异动解读 | 南向资金抛售引发巨子生物盘中大跌5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1187044096","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187044096?lang=zh_cn&edition=full","pubTime":"2024-11-11 10:14","pubTimestamp":1731291272,"startTime":"0","endTime":"0","summary":"2024年11月11日,巨子生物(02367)盘中大跌5%,引发市场广泛关注。分析人士指出,导致股价大跌的主要原因是南向资金大量抛售该股所致。\n\n数据显示,11月8日,南向资金当天净卖出巨子生物98.91万股,连续3日有减持行为。截至当日收盘,港股通共持有该股17518.22万股,占流通股17.03%。港股通在近5个交易日和近20个交易日内都是净减持该股的状态。\n\n大量机构投资者抛售巨子生物股票的原因目前尚不明确,但资金的流出无疑加剧了股价的下跌压力。在今日早盘,巨子生物更是一度大跌5%,报53.15港元/股。不过该股基本面依然保持良好,公司继续保持高增长,投资者也需要冷静看待短期股价波动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | 南向资金抛售引发巨子生物盘中大跌5%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02367"],"gpt_icon":0},{"id":"2482435822","title":"巨子生物盘中异动 早盘大幅下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482435822","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482435822?lang=zh_cn&edition=full","pubTime":"2024-11-11 09:59","pubTimestamp":1731290342,"startTime":"0","endTime":"0","summary":"2024年11月11日早盘09时59分，巨子生物股票出现异动，股价急速跳水5.00%。截至发稿，该股报53.150港元/股，成交量67.24万股，换手率0.07%，振幅3.75%。机构评级方面，在所有25家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。巨子生物股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，科济药业-B、贝康医疗-B、同源康医药-B涨幅较大，振幅较大的相关个股有科济药业-B、和誉-B、宜明昂科-B，振幅分别为17.06%、9.96%、6.98%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111109590298e41a5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111109590298e41a5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1207","02367"],"gpt_icon":0},{"id":"2482430210","title":"南向资金11月8日净卖出巨子生物98.91万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2482430210","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482430210?lang=zh_cn&edition=full","pubTime":"2024-11-11 09:30","pubTimestamp":1731288617,"startTime":"0","endTime":"0","summary":"11月8日，南向资金减持巨子生物98.91万股连续3日减持。截止当日收盘，港股通共持有巨子生物17518.22万股，占流通股17.03%。港股通减持金额前五个股分别为泡泡玛特、中通快递-W、华泰证券、快手-W、中国财险。巨子生物近5个交易日上涨4.38%，港股通累计减持82.11万股；近20个交易日上涨6.98%，港股通累计减持62.19万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111093252a22abfa8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111093252a22abfa8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02367","BK1207"],"gpt_icon":0},{"id":"2481117886","title":"【券商聚焦】招银国际：受益于海外降息以及国内宏观环境改善 医药作为高弹性行业有望跑赢市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2481117886","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481117886?lang=zh_cn&edition=full","pubTime":"2024-11-08 14:54","pubTimestamp":1731048893,"startTime":"0","endTime":"0","summary":"该行认为，宏观经济的表现与医保基金的收支、医疗健康消费息息相关。随着政策焦点转向刺激经济，该行认为医疗设备更新政策有望加速落地、创新药支持政策也有望在各地落地。CXO板块有望受益于海外研发需求复苏，《生物安全法案》的影响或将有限。该行推荐买入药明康德、百济神州、信达生物、联影医疗、巨子生物、三生制药、科伦博泰。","market":"nz","thumbnail":"https://static.szfiu.com/news/20210810/NGI5ZWE4NDg5Y2ExYTk3MGU2NzMxODA4MzkxNTM=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NGI5ZWE4NDg5Y2ExYTk3MGU2NzMxODA4MzkxNTM=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1947380","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","02359","BK1574","LU0708995583.HKD","BK1583","HK0000934320.USD","09939","BK1161","BK1207","LU2328871848.SGD","02367","BK1141","159938","LU0320764599.SGD","LU2125910500.SGD","BK1589","01801","LU1969619763.USD","BK1593","LU1046422090.SGD","LU0196878994.USD","LU2488822045.USD","LU2045819591.USD","BK1576","LU0052750758.USD","LU2242644610.SGD","BK1515","01530"],"gpt_icon":0},{"id":"2481110345","title":"海通证券：消费预期修复+新一轮调优变革开启 重视零批4Q边际变化","url":"https://stock-news.laohu8.com/highlight/detail?id=2481110345","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481110345?lang=zh_cn&edition=full","pubTime":"2024-11-08 14:53","pubTimestamp":1731048795,"startTime":"0","endTime":"0","summary":"海通证券主要观点如下：商超：短期经营承压，超市开启新一轮调优变革期三季度消费环境仍偏弱，线下零售客流仍整体承压，而直营模式下费用刚性，致利润降幅更大。3Q24板块总收入同比增长4.1%，环比2Q24提升5.7pct；板块归母净利润同比增长6.9%，归母净利率28.21%同比提升0.7pct。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1208430.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0348788117.USD","LU0164872284.USD","BK1147","LU0314109678.HKD","LU0054450605.USD","LU0043850808.USD","LU0106252389.USD","LU0348827113.USD","BK1583","LU0214875030.USD","LU0269904917.USD","LU0320764755.SGD","LU0163747925.USD","LU0173614495.USD","IE00BZ08YS42.EUR","LU0164880469.USD","BK1608","IE00B29SXG58.USD","LU0072462343.USD","600837","LU0307460666.USD","LU0370786039.SGD","BK1610","HBBD.SI","BK1604","LU0211977185.USD","IE00BPRC5H50.USD","LU0011963245.USD","06837","LU0359202008.SGD","LU0029874905.USD","LU0231483743.USD","BK1591","IE00BZ08YR35.GBP","BK1249","LU0051755006.USD","BK0188","IE0003895053.USD","02367","LU0359201612.USD","LU0067412154.USD","IE00BZ08YT58.USD","LU0132412106.USD","LU0054237671.USD","89988","IE00B0JY6N72.USD","LU0127658192.USD"],"gpt_icon":1},{"id":"2481169907","title":"巨子生物11月7日遭南向资金减持76.36万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2481169907","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481169907?lang=zh_cn&edition=full","pubTime":"2024-11-08 09:30","pubTimestamp":1731029416,"startTime":"0","endTime":"0","summary":"11月7日，南向资金减持巨子生物76.36万股。截止当日收盘，港股通共持有巨子生物17617.12万股，占流通股17.12%。巨子生物近5个交易日上涨6.05%，港股通累计减持22.40万股；近20个交易日上涨10.32%，港股通累计增持48.33万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108093209a2222187&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108093209a2222187&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1207","02367"],"gpt_icon":0},{"id":"2481174922","title":"国信证券：2024年“双11”电商大促整体平稳增长 美妆品牌分化加剧","url":"https://stock-news.laohu8.com/highlight/detail?id=2481174922","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481174922?lang=zh_cn&edition=full","pubTime":"2024-11-07 17:09","pubTimestamp":1730970589,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，国信证券发布研报称，本次双11进程过半，从目前数据来看整体表现平稳，其中综合电商平台稳健，直播电商仍实现快速增长。事件：2024年“双11”电商大促第一阶段结束，电商平台和品牌方也公布主要交易数据。从品类表现来看，前十品类和2023年“双11”全期相同，除家居建材从第8跃升至第6，电脑办公排名下滑外，其余各品类排名均保持不变。整体仍保持稳健增长态势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1208018.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002736","02145","BK0188","BK0276","02367","BK0183","BK1207","BK0028"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xajuzi.com","stockEarnings":[{"period":"1week","weight":-0.0369},{"period":"1month","weight":-0.0415},{"period":"3month","weight":0.2522},{"period":"6month","weight":-0.0093},{"period":"1year","weight":0.4235},{"period":"ytd","weight":0.4235}],"compareEarnings":[{"period":"1week","weight":-0.0092},{"period":"1month","weight":-0.0548},{"period":"3month","weight":0.1307},{"period":"6month","weight":0.0421},{"period":"1year","weight":0.1061},{"period":"ytd","weight":0.1535}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"巨子生物控股有限公司是一家中国的投资控股公司。该公司通过其子公司主要从事基于生物活性材料的美容和健康产品的研发、生产和销售。该公司的主要产品包括功能性护肤品和医用敷料，其产品的关键生物活性成分为重组胶原蛋白。该公司还开发和生产基于人参皂苷技术的稀有功能食品。该公司主要在国内市场开展其业务。","exchange":"SEHK","name":"巨子生物","nameEN":"GIANT BIOGENE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"巨子生物(02367)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供巨子生物(02367)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"巨子生物,02367,巨子生物股票,巨子生物股票老虎,巨子生物股票老虎国际,巨子生物行情,巨子生物股票行情,巨子生物股价,巨子生物股市,巨子生物股票价格,巨子生物股票交易,巨子生物股票购买,巨子生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"巨子生物(02367)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供巨子生物(02367)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}